Loading...

AIM ImmunoTech Inc.

AIM•AMEX
Healthcare
Biotechnology
$0.41
$0.003(0.74%)
U.S. Market opens in 10h 9m

AIM ImmunoTech Inc. (AIM) Stock Overview

Explore AIM ImmunoTech Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4M
P/E Ratio-0.13
EPS (TTM)$-8.62
ROE2.62%
Fundamental Analysis

AI Price Forecasts

1 Month$0.99
3 Months$3.97
1 Year Target$3.27

AIM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AIM ImmunoTech Inc. (AIM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.13 and a market capitalization of 1.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.50%
5-Day Change
52.41%
1-Month Change
-23.29%
3-Month Change
-62.66%
6-Month Change
-68.56%
Year-to-Date (YTD) Change
-62.99%
1-Year Change
-95.06%
3-Year Change
-99.05%
5-Year Change
-99.79%
All-Time (Max) Change
-95.15%

Contact Information

https://aimimmuno.com
352 448 7797
2117 SW Highway 484, Ocala, FL, 34473

Company Facts

21 Employees
IPO DateNov 2, 1995
CountryUS
Actively Trading

Frequently Asked Questions